SiBionics announced that it has raised CNY 500 million in a round of funding led by Shanghai Biomedical Industry Equity Investment Fund Partnership (LP), a fund managed by Shanghai Shangshi Capital Management Co., Ltd. and Guangdong Traditional Chinese Medicine Great Health Equity Investment Fund Partnership Ent. (L.P.), a fund managed by Guangdong Kaiheng Private Equity Investment Fund Management Co., Ltd. in December 21, 2022. The transaction also included participation from Next Capital, China Industrial Securities International Capital Limited and China New Town Development Company Limited.
China New Town Development Company Limited
Equities
1278
VGG2156N1006
Real Estate Development & Operations
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 HKD | +2.94% | -4.11% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 87.13M | |
+14.64% | 29.29B | |
+36.86% | 28.36B | |
-8.82% | 25.5B | |
+13.69% | 24.47B | |
+50.95% | 23.83B | |
+11.92% | 21.57B | |
+1.39% | 19.32B | |
+31.19% | 16.73B | |
-1.82% | 15.96B |
- Stock Market
- Equities
- 1278 Stock
- News China New Town Development Company Limited
- SiBionics announced that it has received CNY 500 million in funding from Next Capital, China Industrial Securities International Capital Limited, Guangdong Kaiheng Private Equity Investment Fund Management Co., Ltd., China New Town Development Company Limited, Shanghai Shangshi Capital Management Co., Ltd.